Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Ampiwel C Injection
Ampiwel C Injection provides dual-action antibiotic coverage with Ampicillin 250mg and Cloxacillin 250mg. This combination offers reliable treatment for a wide range of bacterial infections, particularly those involving beta-lactamase-producing organisms.
Uses of Ampiwel C Injection
Treatment of respiratory tract infections, including pneumonia and bronchitis
Management of skin and soft tissue infections, such as cellulitis and abscesses
Effective against bone and joint infections, including osteomyelitis
Useful for urinary tract infections (UTIs) and post-surgical infections
Covers infections caused by beta-lactamase-producing staphylococci and other susceptible bacteria
Benefits of Ampiwel C Injection
Broad-spectrum activity, combining Ampicillin and Cloxacillin
Effective against resistant organisms, providing an edge over traditional penicillins
Proven safety and efficacy, trusted by healthcare professionals
Flexible dosing and administration routes, suitable for a variety of clinical settings
Supports faster recovery, reducing the duration and severity of infections
Mechanism of Action of Ampiwel C Injection
Ampicillin inhibits bacterial cell wall synthesis, leading to bacterial death.
Cloxacillin resists beta-lactamase enzymes, ensuring effectiveness against resistant staphylococcal strains.
Together, they provide comprehensive bacterial coverage, supporting rapid infection clearance.